MedTrace Logo

Prospective Cohort Study in Patients With NAFLD

NCT00575133 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2012-02-24

No results posted yet for this study

Summary

To assess the importance of intracellular signalling pathways and its deregulation in adiposity and diabetes-related insulin resistance, liver tissue samples of patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)will be analyzed prospectively from a liver tissue bank.

Conditions

  • Non-alcoholic Fatty Liver Disease

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Giatgen Spinas, Prof. MD · University Hospital Zurich, Endocrinology and Diabetology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Completion
2027-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575133 on ClinicalTrials.gov